WHO’s emergency use authorisation for Covaxin further delayed: Sources

All the relevant trial data has been submitted to WHO, and all clarifications by the UN health agency have been responded to Bharat Biotech.

Comments

Leave a Reply

Your email address will not be published. Required fields are marked *